RaQualia Pharma Inc. (TYO:4579)
1,003.00
+3.00 (0.30%)
Feb 6, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 26.09 billion as of February 6, 2026. Its market cap has increased by 207.94% in one year.
Market Cap
26.09B
Enterprise Value
25.60B
Revenue
3.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,003.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has increased from 19.90B to 26.09B, an increase of 31.11%. That is a compound annual growth rate of 1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 26.09B | 5.63% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncolys BioPharma | 50.53B |
| Healios K.K. | 43.17B |
| AnGes | 22.56B |
| Japan Tissue Engineering | 21.48B |
| Renascience | 19.49B |
| StemRIM | 17.80B |
| CanBas | 17.37B |
| ReproCELL | 15.43B |